Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.
Replication-defective mutants of herpes simplex virus type 1 (HSV-1) may prove useful as vectors for gene transfer, particularly to nondividing cells. Cgal delta 3 is an immediate-early gene 3 (IE 3) deletion mutant of HSV-1 that expresses the lacZ gene of Escherichia coli from the human cytomegalovirus immediate-early control region but does not express viral early or late genes. This vector was able to efficiently infect and express lacZ in cells refractory to traditional methods of gene transfer. However, 1 to 3 days postinfection, Cgal delta 3 induced cytopathic effects (CPE) in many cell types, including neurons. In human primary fibroblasts Cgal delta 3 induced chromosomal aberrations and host cell DNA fragmentation. Other HSV-1 strains that caused CPE, tested under conditions of viral replication-inhibition, included mutants of the early gene UL42, the virion host shutoff function, single mutants of IE 1, IE 2, and IE 3, and double mutants of IE 3 and 4 and IE 3 and 5. Inhibition of viral gene expression by UV irradiation of virus stocks or by preexposure of cells to interferon markedly reduced the CPE. We conclude from these studies that HSV-1 IE gene expression is sufficient for the induction of CPE, although none of the five IE gene products appear to be solely responsible. After infection of human fibroblasts with Cgal delta 3 at a low multiplicity of infection, we were able to recover up to 6% of the input virus 2 weeks later by a superinfection-rescue procedure, even though the virally transduced human cytomegalovirus-lacZ transgene was not expressed at this time. It is therefore likely that inhibition or inactivation of viral IE gene expression, either for establishing latency or for the long-term transduction of foreign genes by HSV-1 vectors, is essential to avoid the death of infected cells.
Johnson
P A
PA
Department of Pediatrics, University of California, San Diego, La Jolla 92093-0634.
Miyanohara
A
A
Levine
F
F
Cahill
T
T
Friedmann
T
T
D000818:Animals; D016923:Cell Death; D002869:Chromosome Aberrations; D003587:Cytomegalovirus / Q000235:genetics; D004249:DNA Damage; D004274:DNA, Recombinant; D004926:Escherichia coli / Q000235:genetics; D005069:Evaluation Studies as Topic; D005347:Fibroblasts / Q000473:pathology; D015967:Gene Expression Regulation, Viral; D005822:Genetic Vectors; D006561:Herpes Simplex / Q000235:genetics / Q000473:pathology*; D006790:Host-Parasite Interactions; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D007763:Lac Operon / Q000235:genetics; D009154:Mutation; D018139:Simplexvirus / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D014466:Ultraviolet Rays; D014779:Virus Replication
D004274:DNA, Recombinant; D007372:Interferons